iRhythm Technologies 주식 (NASDAQ: IRTC)

에 대한 최신 뉴스 iRhythm Technologies (NASDAQ:IRTC) 주식

iRhythm Technologies

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Mid Cap

News

Movers

Trading Ideas

$BTC

IBRX

IONQ

IRTC

WULF

이들 10개 중형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 이뮤니티바이오(NASDAQ:IBRX)의 주식은 회사가 재발성 B-세포 비호지킨 림프종에 대한 CAR-NK 세포 치료제의 1상 임상 연구에서 첫 환자에게 투여했다고 발표한 후 49.86% 상승했다.

트럼프 미디어와 스트라이드는 지난주 최고 성과를 보여준 10개 중형주 중 일부 (10월 21일-10월 25일)

AMKR

BILI

BRFS

ITCI

OLLI

RKLB

TALO

이들 중형주들은 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 빌리빌리(NASDAQ:BILI)의 주가는 지난주 &#39;산구오: 무딩티엔샤(San Guo: Mou Ding Tian Xia)&#39; 발표 이후 23.32% 상승했다. 또한 JP모건 애널리스트 다니엘 첸(Daniel Chen)은 중국의 빌리빌리를 중립에서 비중확대로 상향 조정하고 21달러 가격 목표를 발표했다. 

빌리빌리와 올리즈 바겐은 지난주 최대 성과를 보인 10개 중형주 중 일부 (6월 16일-6월 22일)

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies Inc

Insider Trades

Proficient Auto Logistics Form4 Filing Shows CEO Richard D Odell Bought 54,000 Shares At An Average Price Of $9.20/Share

The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) provided a look at multi-year guidance, which surprised analysts and resulted in price targets being raised after the company&#8217;s <a href="https://www.benzinga.com/24/11/41971559/disneys-q4-boosted-by-streaming-gains-strong-box-office-and-solid-parks-performance">fourth-quarter financial results. </a>
The Disney Analysts:
<ul>
<li>Guggenheim analyst Michael Morris maintained a Buy rating on Disney and raised the price target from $110 to $130.</li>
<li>Macquarie analyst Tim Nollen maintained a Neutral rating and raised the price target from $91 to $110.</li>
<li>Goldman Sachs analyst Michael Ng maintained a Buy rating and raised the price target from $125 to $135.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/11/41953395/disney-q4-earnings-preview-disney-profitability-deadpool-box-office-success-top-items-to-watch">Disney Q4 Earnings Preview: Disney+ Profitability, Deadpool Box Office Success Top Items To Watch</a>
Guggenheim on DIS: Multi-year guidance provided by Disney could help instill confidence in a path for long-term growth, Morris said in a new investor note.
The analyst said fourth-quarter results saw direct-to-consumer profit come in ahead of estimates with linear networks lagging.
"Key incremental item is the detailed, multi-year financial guidance, which includes FY25 EPS growth ahead of consensus and acceleration to double-digit growth in 2026 and 2027," Morris said.
The analyst said entertainment, DTC and studio growth are expected to offset the continued pressure on linear networks.
"We see ESPN Flagship launch, consolidated entertainment growth, parks profit expansion and succession clarity as core components of the BUY thesis into 2025."
Macquarie on DIS: There was a lot to like in Disney's fourth-quarter results and guidance, Nollen said in a new investor note.
"Disney's F4Q report contained positive and detailed guidance for FY25-27 that speak to its long-term potential," Nollen said.
DTC profitability, the success of big blockbuster films, and advertising stability were highlights for the analyst in the fourth quarter.
The analyst also said Disney's guidance was richer than usual.
While the quarter was strong, the analyst remains Neutral, given near-term risks and concerns about the stock&#8217;s valuation, with shares trading at 20x PE and 12x FY25 EV/EBITDA.
Nollen is concerned that the ESPN DTC Flagship launch could include trade-offs with linear subscribers.
"Disney is the one traditional media company that we can be confident will transition successfully to streaming. The positive detailed guidance is encouraging, and sentiment could carry the stock."
Goldman Sachs on DIS: Theme park recovery, DTC strength and the multi-year outlook were highlights in the fourth quarter for Ng.
"DIS provided a 3-year outlook that exceeded even our above-consensus expectations," Ng said.
The analyst said the guidance for fiscal 2025, 2026 and 2027 was better than expected and shows strength across several key segments.
"DIS expects its F2025 results to reflect progression in profitably scaling its streaming businesses with attractive margins and continued investments to grow its Experiences business."
The analyst is watching the launch of ESPN Flagship, upcoming movies like "Moana 2" and "Mufasa,&#8221; the company's upcoming theme park expansions and new cruise ships for future growth.
"We are Buy-rated on DIS as we believe the company is a high-quality EPS compounder."
DIS Price Action: Disney stock is up 3.6% to $113.07 on Friday versus a 52-week trading range of $83.91 to $123.74. Disney stock is up 25% year-to-date in 2024.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/41999904/disney-ceo-bob-iger-slams-the-brakes-on-new-ma-amid-comcasts-cable-spinoff-we-dont-need-more-assets-to-compete-in-todays-disruptive-media-landscape">Bob Iger Slams The Brakes On New M&amp;A Amid Comcast&#8217;s Cable Spinoff: Disney Doesn&#8217;t &#8216;Really Need More Assets&#8217; To Compete</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Entertainment

Price Target

Reiteration

Sports

Analyst Ratings

Disney Q4 Report Had 'A Lot To Like': Analyst Calls It A 'High-Quality' Profit Growth Performer

RBC Capital analyst Rishi Jaluria reiterates NICE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NICE#NASDAQ">NICE</a>) with a Outperform and maintains $260 price target.

NICE

RBC Capital Reiterates Outperform on NICE, Maintains $260 Price Target

WIIM

IMNM

Immunome shares are trading lower on continued weakness after the company on Wednesday reported worse-than-expected Q3 EPS results.

DA Davidson analyst Manuel Navas maintains Provident Finl Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFS#NYSE">PFS</a>) with a Buy and raises the price target from $24 to $27.

DA Davidson Maintains Buy on Provident Finl Servs, Raises Price Target to $27

RBC Capital analyst Elvira Scotto reiterates Plains All American (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) with a Sector Perform and maintains $19 price target.

RBC Capital Reiterates Sector Perform on Plains All American, Maintains $19 Price Target

Loop Capital analyst Alan Gould maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and raises the price target from $120 to $125.

Loop Capital Maintains Buy on Walt Disney, Raises Price Target to $125

RBC Capital analyst Sabahat Khan reiterates Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) with a Outperform and maintains $52 price target.

TTEK

RBC Capital Reiterates Outperform on Tetra Tech, Maintains $52 Price Target

PepsiCo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) shares are trading lower by 3.75% to $158.97 Friday afternoon. Shares of beverage and packaged food stocks are trading lower after President-elect Donald Trump indicated he would nominate Robert F. Kennedy Jr. to <a href="https://www.benzinga.com/government/regulations/24/11/41993115/trump-taps-rfk-jr-for-health-secretary-role-sends-5-vaccine-stocks-lower">lead the HHS</a>.
What To Know: Kennedy's history of criticizing corporate influence on public health has raised concerns about potential regulatory shifts targeting key sectors of PepsiCo&#8217;s diversified business.
As a global leader in beverages and snacks, PepsiCo's portfolio includes sugary soft drinks, such as Pepsi and Mountain Dew, alongside snacks like Doritos and Lay's, as well as healthier offerings under brands like Quaker and Naked Juice. 
Analysts warn that Kennedy's stance on the &#8220;industrial food complex&#8221; could lead to stricter rules on sugar content, marketing practices, and nutritional labeling.
With U.S. consumers already <a href="https://www.benzinga.com/general/biotech/24/07/39656549/exclusive-glp-1-weight-loss-drugs-could-become-a-trillion-dollar-market-predicts-tema-etfs-ceo">gravitating toward healthier options</a>, any heightened regulatory scrutiny on sugary beverages and processed snacks could pressure PepsiCo's core businesses. In addition, possible restrictions on marketing to children, a key demographic for many of its products, could further impact growth.
Read Also: <a href="https://www.benzinga.com/news/retail-sales/24/11/42008180/october-retail-sales-top-expectations-as-us-consumers-increase-tech-spending">October Retail Sales Top Expectations As US Consumers Increase Tech Spending</a>
<h2 class="wp-block-heading">How To Buy PEP Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in PepsiCo&#8217;s case, it is in the Consumer Staples sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, PEP has a 52-week high of $183.39 and a 52-week low of $158.03.

Why Pepsi Stock Is Falling

Loop Capital analyst Jeffrey Stevenson maintains BrightView Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BV#NYSE">BV</a>) with a Buy and raises the price target from $18 to $20.

Loop Capital Maintains Buy on BrightView Hldgs, Raises Price Target to $20

DA Davidson analyst Michael Shlisky maintains Miller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLR#NYSE">MLR</a>) with a Buy and maintains $82 price target.

DA Davidson Maintains Buy on Miller Industries, Maintains $82 Price Target

RBC Capital analyst Luca Issi reiterates bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) with a Sector Perform and maintains $4 price target.

BLUE

RBC Capital Reiterates Sector Perform on bluebird bio, Maintains $4 Price Target

Maxim Group analyst Jason McCarthy maintains Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) with a Buy and raises the price target from $60 to $110.

BLTE

Maxim Group Maintains Buy on Belite Bio, Raises Price Target to $110

In the tech world, few <a href="https://www.benzinga.com/markets/24/10/41457050/bill-gates-once-said-he-was-so-jealous-of-apples-steve-jobs-and-labeled-him-a-genius-and-wizard-no-o">rivalries are as legendary</a> as that between Apple's Steve Jobs and <a href="https://www.benzinga.com/general/education/24/10/41580000/bill-gates-turns-69-5-things-you-might-not-know-about-microsoft-co-founder">Microsoft's Bill Gates</a>. The two pioneers changed the personal computer industry and how we use technology by pushing the envelope in their special ways for decades. However, when asked about his relationship with Gates in a rare joint interview, Jobs didn&#8217;t respond with competitiveness or rivalry – instead, he quoted a line from a Beatles song.
Don't Miss:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before closing date.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
During the 2007 <a href="https://www.youtube.com/watch?v=wvhW8cp15tk">interview</a>, Jobs and Gates reminisced about their long history in the industry. They laughed, remembering their early years when they were frequently the youngest in the room. Gates noted how it was always wonderful to see someone like Jobs persevere through the many challenges and trends offered by the rapidly changing computer sector.&nbsp;
Jobs, known for his passion for music, quoted The Beatles' reflective line: "You and I have memories longer than the road that stretches out ahead,&#8221; before adding, &#8220;And that&#8217;s clearly true here.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When Steve Jobs was asked about his relationship with competitor and business rival, Bill Gates, he answered with a lyric from this reflective Beatles song: <a href="https://t.co/CovfClpMim">pic.twitter.com/CovfClpMim</a>
&mdash; The Beatles Earth (@BeatlesEarth) <a href="https://twitter.com/BeatlesEarth/status/1856357686956237143?ref_src=twsrc%5Etfw">November 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
The lyric from The Beatles' "Two of Us" <a href="https://www.youtube.com/watch?v=cLQox8e9688">song</a> perfectly captured the sentiment. For all their competition, Jobs and Gates shared a deep mutual respect. The song is about friendship, shared memories and a sense of journey – and that's exactly how Jobs saw his connection with Gates. After all, they'd both been through the ups and downs of building billion-dollar companies, watching trends come and go and surviving the intense pressures of leading groundbreaking tech firms.
It was a moment that showed the softer side of their relationship and that despite being rivals, Jobs and Gates weren't just competing tech CEOs – they were two individuals who'd shared a unique journey in an industry they helped to shape. Their antagonism had subsided into camaraderie based on mutual knowledge of what it required to get to where they were, shared experiences and the <a href="https://www.benzinga.com/personal-finance/24/10/41340693/bill-gates-saved-rival-apple-from-bankruptcy-by-investing-150-million-steve-jobs-thanked-him-pub">rare act of cooperation</a>.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Back in the late '70s and early '80s, Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) was working hard to get its personal computers into homes, schools and offices, aiming to make computers friendly, accessible and even stylish. Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), on the other hand, was all about software under Gates&#8217; direction. Gates aimed to install Microsoft&#8217;s operating system on as many machines as possible, including IBM, Apple&#8217;s main rival. And a long-standing rivalry was sparked by this action.&nbsp;
Microsoft's Windows operating system, <a href="https://www.benzinga.com/tech/24/11/41872487/bill-gates-introduced-windows-41-years-ago-today-heres-how-much-youd-have-if-you-invested-1000-in-microsoft-when-it-went-public">introduced in 1983</a>, was strikingly similar to Apple's Mac OS and Jobs was not happy about it. He famously accused Gates of copying Apple&#8217;s interface, saying that Microsoft had no shame in borrowing ideas.
Ultimately, this brief Beatles reference from Jobs was a reminder of the humanity behind the industry giants. For those who grew up with either an Apple device or Microsoft software – most of us have used both – their partnership and rivalry have always felt like a part of our own experience with technology.
Read Next:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in 2 weeks.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
</ul>

Startups

AAPL

MSFT

When Asked About His Business Rivalry With Bill Gates, Steve Jobs Replied With A Beatles Lyric From This Reflective Song

U.S. stocks traded lower midway through trading, with the S&amp;P 500 falling by over 1% on Friday.
The Dow traded down 0.90% to 43,356.00 while the NASDAQ fell 2.26% to 18,676.22. The S&amp;P 500 also fell, dropping, 1.42% to 5,864.40.
Check This Out: <a href="https://www.benzinga.com/24/11/42005109/top-4-utilities-stocks-that-may-keep-you-up-at-night-this-quarter">Top 4 Utilities Stocks That May Keep You Up At Night This Quarter</a>
Leading and Lagging Sectors Energy shares rose by 0.4% on Friday.
In trading on Friday, information technology shares fell by 1.9%.
Top Headline
U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, and toping market estimates of 0.3%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) shares shot up 232% to $1.89 after it announced its first ever profitable quarter.</li>
<li>Shares of Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) got a boost, surging 49% to $19.80. Bloom Energy announced a 1 GW fuel cell deal with AEP, providing clean power for AI Data Centers.</li>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) shares were also up, gaining 90% to $1.6601 after the company announced a $400,000 contract to supply autonomous cleaning robots at Singapore&#8217;s International Airport Terminal.</li>
</ul>
Equities Trading DOWN
<ul>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) shares dropped 78% to $0.3581 after the company announced it will wind down its operations.</li>
<li>Shares of Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) were down 73% to $0.0932 after the company announced that its CHAPERONE trial is not meeting its primary endpoint, prompting the discontinuation of the study and a review of the full data set to evaluate next steps for the program.</li>
<li>Ryvyl Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) was down, falling 33% to $1.1724 after the company reported worse-than-expected third-quarter financial results and cut its FY24 sales guidance.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $68.35 while gold traded up 0.2% at $2,579.20.
Silver traded up 0.7% to $30.79 on Friday, while copper rose 0.8% to $4.1220.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.58%, Germany's DAX fell 0.16% and France's CAC 40 fell 0.26%. Spain's IBEX 35 Index gained 0.82%, while London's FTSE 100 fell 0.06%.
The annual inflation rate in Italy increased to 0.9% in October versus 0.7% in the prior month, while France&#8217;s annual inflation rate rose to 1.2% in October. The GDP in the UK grew by 1% year-over-year during the third quarter.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei 225 gaining 0.28%, Hong Kong's Hang Seng Index falling 0.05% and China's Shanghai Composite Index dipping 1.45%.
Hong Kong's economy expanded by 1.8% year-over-year in the third quarter compared to a 3.2% increase in the previous period. China&#8217;s retail sales rose by 4.8% year-over-year in October, while industrial production rose by 5.3% year-over-year in October.
Economics
<ul>
<li>The NY Empire State Manufacturing Index surged to 31.2 in November versus -11.9 in the previous month and topping market estimates of -0.7.</li>
<li>U.S. export prices increased by 0.8% in October, while import prices rose by 0.3% month-over-month in October.</li>
<li>U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, and toping market estimates of 0.3%.</li>
<li>U.S. industrial production declined by 0.3% in October compared to a revised 0.5% declined in September.</li>
<li>U.S. business inventories rose 0.1% month-over-month in September compared to a 0.3% gain in August and versus market estimates of 0.2%.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42007351/wall-streets-most-accurate-analysts-spotlight-on-3-consumer-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Consumer Stocks With Over 7% Dividend Yields</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

AREN

EYEN

RVYL

SPPL

TFFP

S&P 500 Down Over 1%; US Retail Sales Top Expectations

Maxim Group analyst Allen Klee maintains Dolphin Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) with a Buy and lowers the price target from $8 to $5.

DLPN

Maxim Group Maintains Buy on Dolphin Entertainment, Lowers Price Target to $5

RBC Capital analyst Tom Narayan maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and raises the price target from $249 to $313.

TSLA

RBC Capital Maintains Outperform on Tesla, Raises Price Target to $313

DA Davidson analyst Linda Bolton Weiser maintains Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) with a Neutral and raises the price target from $12 to $13.

DA Davidson Maintains Neutral on Sally Beauty Holdings, Raises Price Target to $13

Maxim Group analyst Michael Diana maintains FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) with a Buy and raises the price target from $2 to $4.

FPAY

Maxim Group Maintains Buy on FlexShopper, Raises Price Target to $4

DA Davidson analyst Michael Baker maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Neutral and maintains $45 price target.

DA Davidson Maintains Neutral on Advance Auto Parts, Maintains $45 Price Target

iRhythm (IRTC) Technologies announced that the U.S. FDA has granted clearance for its 510(k) submission related to design modifications and labelin...

iRhythm gets FDA 510(k) clearance for design modifications to Zio AT device

iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript

Analyst Kallum Titchmarsh from Morgan Stanley maintained a Buy rating on Irhythm Technologies (IRTC – Research Report) and keeping the price target...

Irhythm Technologies: Buy Rating Affirmed on Promising Growth Prospects and Regulatory Progress

Truist Financial analyst Richard Newitter maintained a Buy rating on Irhythm Technologies (IRTC – Research Report) today and set a price target of ...

Irhythm Technologies (IRTC) Receives a Buy from Truist Financial

Irhythm Technologies (IRTC) has disclosed a new risk, in the Debt & Financing category. Irhythm Technologies faces a significant risk related to th...

iRhythm Technologies Faces Potential Stockholder Dilution and Market Pressure from 2029 Notes Conversion

Baird lowered the firm's price target on iRhythm (IRTC) to $79 from $100 and keeps an Outperform rating on the shares. The firm said its tough to a...

iRhythm price target lowered to $79 from $100 at Baird

BTIG analyst Marie Thibault maintained a Buy rating on Irhythm Technologies (IRTC – Research Report) yesterday and set a price target of $120.00. T...

Irhythm Technologies (IRTC) Receives a Buy from BTIG

In a report released yesterday, Richard Newitter from Truist Financial maintained a Buy rating on Irhythm Technologies (IRTC – Research Report), wi...

Truist Financial Remains a Buy on Irhythm Technologies (IRTC)

Artisan Global Discovery Fund Q3 2024 Commentary

Baird Q3 2024 Small/Mid Cap Growth Equity Fund Commentary

AAON

ACLS

ALAB

APPF

ARGNF

ARGX

BOOT

BROS

BURL

BWXT

CACI

CASY

CHYHY

COHR

CRTSF

CWAN

CYBR

ESTC

EXLS

FANG

FIVE

FOUR

GALDY

GDERF

GRRMF

GRRMY

GWRE

HUBB

INSP

JKHY

KNSL

LGIH

LSCC

MANH

MEDP

MNDY

MPWR

MTSI

NBIX

NVZMF

NVZMY

ONTO

PCOR

PODD

POOL

PRCT

RXST

SDZNY

SDZXF

SITM

SMPL

TARS

TCOM

TREX

TTNDF

TTNDY

VEEV

VNOM

VWDRY

VWSYF

WING

Press Releases

IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

IRHYTHM INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

General

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

Health Care

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

iRhythm Technologies Announces Third Quarter 2024 Financial Results

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Legal

IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

Comments

iRhythm Technologies

뉴스

에 대한 최신 뉴스 iRhythm Technologies (NASDAQ:IRTC) 주식

월요일, 10월 28, 2024

월요일, 6월 24, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌